$115.94
-0.04-0.03%
At Close: -
$115.94
00.00%
After Hours: Sep 20, 4:01 PM EDT
15 minutes delayed
Comments
Loading...
Latest news for Novartis (NYSE:NVS) Stock
Novartis Stock (NYSE: NVS)
Categories: All
Wednesday, September 18, 2024
- Incyte Downgraded - Analyst Notes Intense Competition, Particularly In Larger Markets
- Novartis Wins FDA Approval of Kisqali for Early Breast Cancer
- Novartis' Multiple Sclerosis Drug Data Shows Most Patients Remain With No Disability Progression For Up To Six Years
- Novartis Announced New Data From ALITHIOS Ope...
- The FDA Approves Novartis' Kisqali (Ribocicli...
Tuesday, September 17, 2024
Monday, September 16, 2024
Wednesday, September 11, 2024
Monday, September 09, 2024
Thursday, September 05, 2024
Tuesday, September 03, 2024
Wednesday, August 28, 2024
Monday, August 26, 2024
Tuesday, August 13, 2024
Thursday, August 08, 2024
Wednesday, August 07, 2024
Tuesday, August 06, 2024
Monday, July 29, 2024
Wednesday, July 24, 2024
Tuesday, July 23, 2024
Thursday, July 18, 2024
- VIX Stages Double-Digit Spike As Risk Off Takes Over; Chipmakers Fail To Rebound, Weight Loss Giants Eli Lilly, Novo Tumble: What's Driving Markets Thursday?
- Novartis Tops on Q2 Earnings, Ups Operating Income View
- Novartis' Q2 Earnings: Revenue And EPS Beat, Raises 2024 Profit Forecast On Strong Demand For Key Drugs
- Novartis shares are trading lower. The compan...
- Wall Street Gearing Up For Tech-Led Rebound Ahead Of Netflix Earnings: Economist Expects Soft Landing But Says Brace For Bigger Fed Rate Cuts If This Happens
- D.R. Horton, Netflix And 3 Stocks To Watch Heading Into Thursday
- Novartis Now Expects 2024 Net Sales To Grow H...
- Novartis Q2 2024 Adj EPS $1.97 Beats $1.89 Es...